- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03667456
Evaluation of the Uses of a Digital-assisted Self-rehabilitation Device (TELE-PARK) (TELE-PARK)
Evaluation of the Uses of a Digital-assisted Self-rehabilitation Device Coupled With a Tele-reeducative Follow-up in Patients With Parkinson's Disease on a Defined Health Area (TELE-PARK)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bretagne
-
Rennes, Bretagne, France, 35000
- Pole Saint Helier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patients:
- Men and women over the age of 18
- With Parkinson's syndrome due to idiopathic Parkinson's disease or related syndromes
- Presenting a complaint about balance and/or walking
- With possible walking over a perimeter of at least 100 meters with or without technical aid
- Hoehn and Yahr scale < or = to 4
- Formulating their free and informed consent in writing.
Health professionals:
- physiotherapists and physiatrists hospital or voluntary volunteers practicing in the territory of health 5 in Brittany agreeing to participate in the study
Exclusion Criteria:
- Orthopedic and rheumatologic pathologies that may prevent the achievement of measures
- Comprehension disorders preventing the implementation of the protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Self-rehabilitation by digital support
Provision to patients selected by doctors or physiotherapists of an interactive digital tool (tablet + inertial sensor) to support self-rehabilitation home Parkinson's patients. Monitoring and regulation of remote self-reeducation by tele-reeducation. Evaluation of the acceptance of the tool and the quality of life of the patients by questionnaire at day 0, and two and twelve months after. |
Provision to patients selected by doctors or physiotherapists of an interactive digital tool (tablet + inertial sensor) to support self-rehabilitation home Parkinson's patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
UTAUT Questionnaire
Time Frame: 12 months
|
Questionnaire of acceptability / acceptance of the tool and its use by professionals based on the Unified Theory of Acceptance and Use Technology (UTAUT).
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
UTAUT Questionnaire
Time Frame: 12 months
|
Questionnaires for integrating the tool and its use at 12 months for professionals and patients / entourage
|
12 months
|
|
Observance
Time Frame: 12 months
|
Observance of self-rehabilitation using tablet data at 2 months and 12 months: the tablet records the number of sessions performed, their duration, the number and type of exercises performed
|
12 months
|
|
SF36
Time Frame: 12 months
|
The 36-Item Short Form Health Survey is assessing the subjective quality of life of patients summarized in two component summary scores, the Physical Component Summary (PCS) and the Mental Component Summary (MCS) scores.
The SF-36 includes one multi-item scale that assesses eight health concepts.
All questions are scored on a scale from 0 to 100, with 100 representing the highest level of functioning possible.
Aggregate scores are compiled as a percentage of the total points possible, using the RAND scoring table.
The scores from those questions that address each specific area of functional health status are then averaged together, for a final score within each of the 8 dimensions measured.
Reliability is measured by Cronbach's alpha coefficient.
Its value is less than or equal to 1.
It is considered "acceptable" from 0.7.
|
12 months
|
|
Rosenberg SES
Time Frame: 12 months
|
Rosenberg's self-esteem scale (SES) assesses self-esteem.
The questionnaire consists of 10 items of which 5 evaluate positive self-esteem and 5 negative self-esteem.
The answer varies according to a four-point Likert-type scale from "Strongly disagree" (1) to "Totally agree" (4).
A score between 10 and 40 is obtained.
A score below 25 means very low self-esteem; a score between 25 and 31 means low self-esteem; a score between 31 and 34 means an average self-esteem; a score between 34 and 39 means a strong self-esteem; a score above 39 means a very strong self-esteem.
|
12 months
|
|
Zarit's Score
Time Frame: 12 months
|
The Zarit scale assesses the emotional, physical and financial burden for caregivers of caring for someone with a loss of autonomy. The 22-item grid allows an assessment of this burden, ranging from mild to moderate to severe. The total score (sum of the 22-item scores) ranges from 0 to 88. A score less than or equal to 20 indicates a low or no burden; a score between 21 and 40 indicates a light burden; a score between 41 and 60 indicates a moderate burden; a score above 60 indicates a severe burden |
12 months
|
|
Performance indicators
Time Frame: 12 months
|
Alternatives that would have been implemented to meet the difficulties of the liberal therapist with his patient, number of kilometers saved by telereducation
|
12 months
|
|
VAS Satisfaction
Time Frame: 12 months
|
The Visual Analogue Scale (VAS) allows a quick estimate of the level of satisfaction of patients by positioning themselves on a line whose extremities indicate the lowest level on the left (0) and the strongest on the right (10)
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Philippe Gallien, Doctor, Pole Saint Helier
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-A02379-44
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.